Julien Pierson

Nancy, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Modern brachytherapy in glioblastoma: overcoming clinical barriers to improve local control.

Modern brachytherapy in glioblastoma: overcoming clinical barriers to improve local control.

Journal: Frontiers in oncology
Published: April 28, 2026

Protocol for developing a surgically operated model to mimic human glioblastoma resection and recurrence.

Protocol for developing a surgically operated model to mimic human glioblastoma resection and recurrence.

Journal: STAR protocols
Published: December 11, 2025

Non-targeted effects of radiation therapy for glioblastoma.

Non-targeted effects of radiation therapy for glioblastoma.

Journal: Heliyon
Published: February 07, 2024

Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy.

Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy.

Journal: ImmunoTargets and therapy
Published: January 05, 2024

Assessment of a one-week ketogenic diet on brain glycolytic metabolism and on the status epilepticus stage of a lithium-pilocarpine rat model.

Assessment of a one-week ketogenic diet on brain glycolytic metabolism and on the status epilepticus stage of a lithium-pilocarpine rat model.

Journal: Scientific reports
Published: October 20, 2023

Clickable C-Glycosyl Scaffold for the Development of a Dual Fluorescent and [18F]fluorinated Cyanine-Containing Probe and Preliminary In Vitro/Vivo Evaluation by Fluorescence Imaging.

Clickable C-Glycosyl Scaffold for the Development of a Dual Fluorescent and [18F]fluorinated Cyanine-Containing Probe and Preliminary In Vitro/Vivo Evaluation by Fluorescence Imaging.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 27, 2022

Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma.

Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma.

Journal: International journal of molecular sciences
Published: October 21, 2022

NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells.

NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells.

Journal: Cancer cell international
Published: September 23, 2022

Preliminary Study of New Gallium-68 Radiolabeled Peptide Targeting NRP-1 to Detect Brain Metastases by Positron Emission Tomography.

Preliminary Study of New Gallium-68 Radiolabeled Peptide Targeting NRP-1 to Detect Brain Metastases by Positron Emission Tomography.

Journal: Molecules (Basel, Switzerland)
Published: October 08, 2021

Synthesis of a DOTA-C-glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68Ga]Ga-DOTA-C-glyco-RGD.

Synthesis of a DOTA-C-glyco bifunctional chelating agent and preliminary in vitro and in vivo study of [68Ga]Ga-DOTA-C-glyco-RGD.

Journal: RSC advances
Published: October 31, 2020

Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma.

Multiscale Selectivity and in vivo Biodistribution of NRP-1-Targeted Theranostic AGuIX Nanoparticles for PDT of Glioblastoma.

Journal: International journal of nanomedicine
Published: May 12, 2020

A 1-week extension of a ketogenic diet provides a further decrease in myocardial 18F-FDG uptake and a high detectability of myocarditis with FDG-PET.

A 1-week extension of a ketogenic diet provides a further decrease in myocardial 18F-FDG uptake and a high detectability of myocarditis with FDG-PET.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Published: May 28, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026